Establishment Labs Holdings Inc. revised earnings guidance for the fiscal year 2021. For the period, the company expects revenue to be $126.4 million to $126.9 million, an increase of 49% to 50% over 2020 and above the mid-point of the Company's current 2021 revenue guidance range of $124 million to $128 million.
Establishment Labs Holdings Inc.
Equities
ESTA
VGG312491084
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.52 USD | -3.00% |
|
+9.72% | +83.55% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.55% | 1.31B | |
-4.90% | 182B | |
-1.36% | 104B | |
-7.64% | 45.58B | |
+9.30% | 46.44B | |
+9.63% | 44.34B | |
+13.63% | 29.44B | |
+20.29% | 26.8B | |
-7.12% | 23.82B | |
+4.03% | 22.61B |
- Stock Market
- Equities
- ESTA Stock
- News Establishment Labs Holdings Inc.
- Establishment Labs Holdings Inc. Revises Earnings Guidance for the Fiscal Year 2021